A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
Journal
Infectious Diseases and Therapy
Series/Report No.
Infectious Diseases and Therapy
Journal Volume
13
Journal Issue
7
Start Page
1575
End Page
1588
Date Issued
2024-07-01
Author(s)
Feng, Po-Hao
Cheng, Chien-Yu
Chou, Chun-Liang
Lee, Chih-Hsin
Lu, Min-Chi
Liu, Po-Yu
Lee, Mei-Hui
Liao, Chun-Hsing
Chen, Mei-Chuan
Chen, Cheng-Pin
Hsu, Shang-Fu
Tzeng, Yu-Tien
Lin, Yi-Chun
Ou, Tsong-Yih
Qin, Albert
Tsai, Chan-Yen
Shih, Weichung Joe
Lee, Kang-Yun
DOI
10.1007/s40121-024-00992-5
SDGs
Type
journal article